천식과 만성폐쇄성폐질환에서 마이크로바이옴 연구 = Current status of microbiome research in asthma and chronic obstructive pulmonary disease

다국어 초록 (Multilingual Abstract)

Asthma and chronic obstructive pulmonary disease (COPD) are characterized by chronic airway inflammation resulting in airflow limitation. They include various phenotypes and endotypes in their disease entities. For that reason, they lack proper biomarkers and epoch-making progresses in treatment nowadays. Healthy airway has been believed to be sterile traditionally. However, with the help of nonculture sequencing techniques, researchers discovered that it is full of the commensal and symbiotic microbial flora. Therefore, microbiome has emerged as a possible biomarker and a clue to understand the pathogenesis of airway disease. Microbiome research in asthma has focused on the association between characteristics of microbiome, such as composition and diversity. However, now it refers to the role of microbiome, including Proteobacteria, in the development and pathogenesis of asthma and allergic diseases. Microbiome research in COPD has revealed its different composition according to the existence and severity of the disease. Also, differences in microbiome composition according to exacerbation state or specific treatment of COPD are reported. Therefore, many researchers pay attention to the possible role of microbiome as a biomarker or a treatment target in asthma and COPD. Herein, we review recent studies on microbiome research in asthma and COPD. (Allergy Asthma Respir Dis 2016:4:321-327)

참고문헌 (Reference)

1 심다운, "성인 천식의 바이오마커와 맞춤의학" 대한 소아알레르기 호흡기학회 4 (4): 4-13, 2016

2 Jackson DJ, "Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children" 178 : 667-672, 2008

3 Cardenas PA, "Upper airways microbiota in antibiotic-naïve wheezing and healthy infants from the tropics of rural Ecuador" 7 : E46803-, 2012

4 Mommers M, "Timing of infection and development of wheeze, eczema, and atopic sensitization during the first 2 yr of life: the KOALA Birth Cohort Study" 21 : 983-989, 2010

5 Huang YJ, "The microbiome in asthma" 135 : 25-30, 2015

6 Pragman AA, "The lung microbiome in moderate and severe chronic obstructive pulmonary disease" 7 : E47305-, 2012

7 Teo SM, "The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development" 17 : 704-715, 2015

8 Cookson W, "The immunogenetics of asthma and eczema: a new focus on the epithelium" 4 : 978-988, 2004

9 Brooks C, "The hygiene hypothesis in allergy and asthma: an update" 13 : 70-77, 2013

10 Goleva E, "The effects of airway microbiome on corticosteroid responsiveness in asthma" 188 : 1193-1201, 2013

11 Murgas Torrazza R, "The developing intestinal microbiome and its relationship to health and disease in the neonate" 31 (31): S29-S34, 2011

12 Huang YJ, "The airway microbiome in patients with severe asthma: Associations with disease features and severity" 136 : 874-884, 2015

13 Garcia-Nuñez M, "Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease" 52 : 4217-4223, 2014

14 Liu AH, "Revisiting the hygiene hypothesis for allergy and asthma" 136 : 860-865, 2015

15 Yasui H, "Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota" 11 : 675-679, 2004

16 Green BJ, "Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma" 9 : E100645-, 2014

17 Ni K, "Pharyngeal microflora disruption by antibiotics promotes airway hyperresponsiveness after respiratory syncytial virus infection" 7 : E41104-, 2012

18 Park HW, "Pharmacogenomics in asthma therapy: where are we and where do we go?" 55 : 129-147, 2015

19 Bisgaard H, "Paludan-Müller G, et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age" 128 : 646-652, 2011

20 Molyneaux PL, "Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease" 188 : 1224-1231, 2013

21 Tomosada Y, "Nasally administered Lactobacillus rhamnosus strains differentially modulate respiratory antiviral immune responses and induce protection against respiratory syncytial virus infection" 14 : 40-, 2013

22 van Nimwegen FA, "Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy" 128 : 948-955, 2011

23 Ichinohe T, "Microbiota regulates immune defense against respiratory tract influenza A virus infection" 108 : 5354-5359, 2011

24 Rautava S, "Microbial contact during pregnancy, intestinal colonization and human disease" 9 : 565-576, 2012

25 Park H, "Microbial communities in the upper respiratory tract of patients with asthma and chronic obstructive pulmonary disease" 9 : E109710-, 2014

26 Gollwitzer ES, "Lung microbiota promotes tolerance to allergens in neonates via PD-L1" 20 : 642-647, 2014

27 Wang Z, "Lung microbiome dynamics in COPD exacerbations" 47 : 1082-1092, 2016

28 Abrahamsson TR, "Low gut microbiota diversity in early infancy precedes asthma at school age" 44 : 842-850, 2014

29 Sze MA, "Loss of GD1-positive Lactobacillus correlates with inflammation in human lungs with COPD" 5 : E006677-, 2015

30 Karimi K, "Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice" 179 : 186-193, 2009

31 Castro-Nallar E, "Integrating microbial and host transcriptomics to characterize asthma-associated microbial communities" 8 : 50-, 2015

32 Panzer AR, "Influence and effect of the human microbiome in allergy and asthma" 27 : 373-380, 2015

33 Webley WC, "Infectious asthma triggers: time to revise the hygiene hypothesis?" 23 : 389-391, 2015

34 Atarashi K, "Induction of colonic regulatory T cells by indigenous Clostridium species" 331 : 337-341, 2011

35 Moore WC, "Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program" 181 : 315-323, 2010

36 Fujimura KE, "House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection" 111 : 805-810, 2014

37 Sze MA, "Host response to the lung microbiome in chronic obstructive pulmonary disease" 192 : 438-445, 2015

38 Strachan DP, "Hay fever, hygiene, and household size" 299 : 1259-1260, 1989

39 Trompette A, "Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis" 20 : 159-166, 2014

40 Russell SL, "Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma" 13 : 440-447, 2012

41 Aaby P, "Early BCG vaccination and reduction in atopy in Guinea-Bissau" 30 : 644-650, 2000

42 Herbst T, "Dysregulation of allergic airway inflammation in the absence of microbial colonization" 184 : 198-205, 2011

43 Pérez-Losada M, "Dual transcriptomic profiling of host and microbiota during health and disease in pediatric asthma" 10 : E0131819-, 2015

44 Kalliomäki M, "Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing" 107 : 129-134, 2001

45 Hilty M, "Disordered microbial communities in asthmatic airways" 5 : E8578-, 2010

46 Matricardi PM, "Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus" 314 : 999-1003, 1997

47 Bisgaard H, "Childhood asthma after bacterial colonization of the airway in neonates" 357 : 1487-1495, 2007

48 Shaheen SO, "Cell mediated immunity after measles in Guinea-Bissau: historical cohort study" 313 : 969-974, 1996

49 Bager P, "Caesarean delivery and risk of atopy and allergic disease: meta-analyses" 38 : 634-642, 2008

50 Sze MA, "Bacterial microbiome of lungs in COPD" 9 : 229-238, 2014

51 Marri PR, "Asthma-associated differences in microbial composition of induced sputum" 131 : 346-352, 2013

52 Hahn DL, "Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma" 266 : 225-230, 1991

53 Erb-Downward JR, "Analysis of the lung microbiome in the "healthy" smoker and in COPD" 6 : E16384-, 2011

54 Strachan DP, "Allergy and family size: a riddle worth solving" 27 : 235-236, 1997

55 Huang YJ, "Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma" 127 : 372-381, 2011

56 Huang YJ, "Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease" 52 : 2813-2823, 2014

57 Simpson JL, "Airway dysbiosis: Haemophilus influenzae and Tropheryma in poorly controlled asthma" 47 : 792-800, 2016